Description
A thymidylate kinase inhibitor (IC50 = 610 nM); selective for thymidylate kinase over thymidine kinase 1; reduces dTTP levels by 30-40% in p58-/- HCT116 cells; sensitizes a variety of cancer cell lines to doxorubicin; reduces tumor growth in a p53-/- HCT116 mouse xenograft model at 5 mg/kg three times per week for four weeks
Formal name: 4-[2-(4,6-dimethyl-3-oxoisothiazolo[5,4-b]pyridin-2(3H)-yl)acetyl]-1-piperazinecarboxylic acid, ethyl ester
Synonyms:
Molecular weight: 378.5
CAS: 902589-96-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Signaling|p53 Signaling||Research Area|Cancer|Metabolism||Research Area|Cancer|Transcription Factors|p53